NIPT – current landscape and future potential
ASUM WEBINARS
•
1h 2m
Join Associate Professor Andrew McLennan for a dive into the rapidly evolving world of prenatal screening for chromosomal and genetic conditions.
This webinar will cover:
- Brief historical perspective of antenatal aneuploidy screening over the past 50 years
- Non-invasive prenatal testing (NIPT)
- How it works and what it tests for.
- Accuracy and false results
- Current status of testing in Australia
- What now for the first trimester ultrasound?
- Future potential of NIPT
- Reproductive genetic screening overview
Learning outcomes:
- Understand the molecular basis of NIPT screening
- Understand why some false results occur
- Understand how NIPT fits into the current screening landscape
- Understand the principles of reproductive genetic screening
Up Next in ASUM WEBINARS
-
Phenocopies of HCM and echocardiograp...
Distinguishing hypertrophic cardiomyopathy (HCM) from its photocopies—such as cardiac amyloidosis, hypertensive left ventricular hypertrophy (LVH), and Fabry disease—is critical for accurate diagnosis and appropriate management. Echocardiographic features help differentiate these conditions; for ...
-
Diagnosis of HCM by echocardiography
Hypertrophic cardiomyopathy (HCM) is a genetic heart condition characterised by abnormal thickening of the heart muscle, particularly the left ventricular (LV) wall. This thickening can obstruct blood flow, impair heart function, and increase the risk of arrhythmias or sudden cardiac events.
Ech...
-
Risk factors of sudden death in HCM p...
Hypertrophic cardiomyopathy (HCM) is a complex cardiac disorder that carries a risk of sudden cardiac death (SCD), particularly in certain high-risk individuals. Echocardiographic evaluation plays a crucial role in identifying risk factors for SCD, with guidelines from both American and European ...
